Search company, investor...
Inotec AMD company logo

Inotec AMD

natroxwoundcare.com

Founded Year

2003

Stage

Series C | Alive

Total Raised

$14.18M

Last Raised

$5.13M | 2 yrs ago

About Inotec AMD

Inotec AMD is the maker of mobile medical devices designed to heal chronic, hypoxic wounds that afflict millions of sufferers around the world every year. The firm develops the NATROX Oxygen Wound Therapy. It is an FDA cleared and CE marked simple device which has been designed to deliver continuous pure humidified oxygen to a wound to stimulate healing

Headquarters Location

nit 7340, Building 7300, Cambridge Research Park

Cambridge, England, CB25 9PD,

United Kingdom

+44(0)1763 209 007

Missing: Inotec AMD's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Inotec AMD's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Inotec AMD

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Inotec AMD is included in 3 Expert Collections, including Medical Devices.

M

Medical Devices

8,562 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

D

Diabetes

1,898 items

H

Health IT

7,901 items

Inotec AMD Patents

Inotec AMD has filed 1 patent.

The 3 most popular patent topics include:

  • Causes of death
  • Diving medicine
  • Industrial gases
patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/21/2018

11/23/2021

Diving medicine, Medical treatments, Industrial gases, Causes of death, Physiology

Grant

Application Date

9/21/2018

Grant Date

11/23/2021

Title

Related Topics

Diving medicine, Medical treatments, Industrial gases, Causes of death, Physiology

Status

Grant

Latest Inotec AMD News

U.S. Topical Oxygen Therapy Market Size, Share, Growth 2022-2030 | Key Players – INOTEC AMD LTD., GWR, AOTI, OXYBAND

Oct 17, 2022

| Key Players – INOTEC AMD LTD., GWR, AOTI, OXYBAND News Provided By Share This Article Rise in incidence of chronic wounds, surge in patient pool of diabetics, and high prominence of wound site infections drive the growth of the market. PORTLAND, OREGON, UNITED STATES, October 17, 2022 / EINPresswire.com / -- According to the report, the global topical oxygen therapy industry was estimated at $19,889.74 thousand in 2021, and is anticipated to hit $27,721.76 thousand by 2031, registering a CAGR of 3.4% from 2022 to 2031. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape. Download Report (150 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/17353 Rise in incidence of chronic wounds, surge in patient pool of diabetics, and high prominence of wound site infections drive the growth of the global topical oxygen therapy market. On the other hand, lack of awareness in developing countries restrains the growth to some extent. However, introduction of topical oxygen therapy in emerging economies is expected to create lucrative opportunities in the industry. Growth in the incidence of chronic wounds, increase in patient pool of diabetics, and high incidence of wound site infections, along with rise in number of surgical procedures and technological advancement in advanced wound care fuel growth of the topical oxygen therapy market. The benefit of this approach is that the higher-pressure gradient (pO2) results in oxygen molecules diffusing deeper into the hypoxic wound tissue to enhance multiple molecular and enzymatic functions. A critical component of wound care is assessment for associated arterial insufficiency. Arterial insufficiency can be the etiology of wound formation or be a limiting factor for the healing. Assessment for arterial insufficiency includes a complete history and physical exam. A screening ankle-brachial index is recommended for chronic lower extremity wounds. If arterial insufficiency is present, the patient should be referred for further workup by a vascular surgeon or specialist. Wounds with associated arterial insufficiency should be considered for revascularization before committing to treatment with hyperbaric or topical oxygen therapy. Following revascularization, topical oxygen therapy may still be indicated if the wound fails to respond to basic wound care. Covid-19 scenario- The outbreak of the pandemic provided wound care clinicians with an opportunity to change the wound treatment paradigm in favor of home-based care solutions. It took in essential wound care to prevent amputations, thus offering relief to a hospital system in crisis. An in-home technology for the delivery of supplementary oxygen to wounds was the main focus of the therapy. These factors impacted the global topical oxygen therapy market positively. Also, removal of strict lockdown and Covid-19 restrictions in 2021 by the majority of the countries coupled with an increase in number of patients visits in hospitals and wound care centers propelled the demand and adoption of wound care devices. Specific Requirement on COVID-19? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/request-for-customization/17353?reqfor=covid By application, the chronic wound segment dominated the market in 2021 and is expected to remain dominant during the topical oxygen therapy market analysis period, owing to growing prevalence of chronic wound specifically in geriatric population suffering from diabetics and wound site infection. Depending on end user, the homecare segment dominated topical oxygen therapy market share in 2021 and is expected to remain dominant during the forecast period, owing to increased costs of medicines & devices, rise in capital costs, and an increase in the numbers of people with chronic conditions require primary and secondary healthcare support. North America Topical Oxygen Therapy Market to Dominate by 2031- By region, North America garnered the major share in 2021, holding more than two-fifths of the global topical oxygen therapy market, owing to supportive reimbursement policies in the healthcare system across the province. Simultaneously, Asia-Pacific would cite the fastest CAGR of 4.9% throughout the forecast period. This is due to growing awareness among people regarding benefits of TOT. Key players in the industry- Inotec AMD Ltd. North America Topical Oxygen Therapy Market Japan Topical Oxygen Therapy Market South Korea Topical Oxygen Therapy Market Singapore Topical Oxygen Therapy Market Australia Topical Oxygen Therapy Market Europe Topical Oxygen Therapy Market Avenue Basic Plan | Library Access | 1 Year Subscription | Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan. Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter About Us Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. David Correa

Inotec AMD Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Inotec AMD Rank

Inotec AMD Frequently Asked Questions (FAQ)

  • When was Inotec AMD founded?

    Inotec AMD was founded in 2003.

  • Where is Inotec AMD's headquarters?

    Inotec AMD's headquarters is located at nit 7340, Building 7300, Cambridge Research Park, Cambridge.

  • What is Inotec AMD's latest funding round?

    Inotec AMD's latest funding round is Series C.

  • How much did Inotec AMD raise?

    Inotec AMD raised a total of $14.18M.

  • Who are the investors of Inotec AMD?

    Investors of Inotec AMD include Wealth Club, Amadeus Capital Partners, Puhua Capital, Praetura Ventures, Boundary Capital and 6 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.